TuHURA Biosciences, Inc. HURA
2.10
0.00
0.00%
as of 25 Sep
- Market cap
- $133.8M
- P/E
- 0.0×
Follow HURA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
0.18 | 1.15 | 0.78 | 0.40 |
+8 more quarters Free account |
Net Debt/EBITDA |
(0.92) | 0.84 | 0.47 | 0.40 | |
Debt/Assets |
27.63% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.47 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.94 | 0.59 | 0.82 | 1.56 | |
Capex/Depreciation |
(0.42) | (2.08) | 2.44 | (59.12) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.34 | 0.36 | 0.39 | 0.53 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.14) | (0.07) | (0.09) | (0.24) | |
Cash per Share |
0.02 | 0.11 | 0.08 | 0.05 | |
Shareholders Equity per Share |
0.29 | 0.39 | 0.44 | 0.33 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.29 | 0.39 | 0.44 | 0.33 | |
Free Cash Flow |
(8.77) | (4.46) | (4.32) | (12.35) | |
Working Capital |
(7.60) | 0.92 | (1.30) | (5.33) | |
Capital Expenditures |
(0.14) | (0.05) | 1.23 | (1.26) | |
Net Current Asset Value |
(11.59) | 0.47 | (1.80) | (5.42) | |
| Other line items | |||||
Quick Ratio |
0.11 | 1.04 | 0.70 | 0.31 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.13) | (0.07) | (0.12) | (0.22) | |
Capex per Share |
0.00 | 0.00 | 0.03 | (0.02) | |
Average Receivables |
— | — | 0.25 | — | |
Average Payables |
7.98 | 5.24 | 5.45 | 3.84 | |
Average Assets |
33.18 | 22.17 | 23.66 | 14.92 | |
Average Common Equity |
18.70 | 16.24 | 17.48 | 8.96 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates